Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic Cancer

NCT04617067 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.

NCT NCT04617067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04617067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic Cancer
Lead sponsor
Cancer Trials Ireland
Phase
Phase 2
Overall status
Completed
Start date
October 16, 2020
Completion date
September 30, 2022
Enrollment
15 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

advanced pancreatic cancer